Background: Reports on the prevalence of different human papillomavirus (HPV) genotypes in male patients with anogenital HPV infection are limited. Methods: We retrospectively analyzed the HPV genotypes of 100 consecutive patients seen in our department with anogenital HPV infection during 2003e2006. History was gathered from the medical records. Results: The most common HPV genotypes among Taiwanese male patients for check of anogenital warts (in descending order) were HPV 6 (46%), HPV 11 (28%), HPV 16 (6%), HPV 33 (5%), HPV 66 (5%), HPV 18 (4%), HPV 53 (4%), and HPV 72 (4%). Coinfections with two, three, and four genotypes of HPV were present in 16%, 7%, and 1% of the patients, respectively. HPV 16 or 18 was found in 10% of cases, with 60% (6/10) coexisting with HPV 6/11. The presence of either HPV 6, 11, 16, or 18 was 77%. HPV 16 was more common in anal compared to genital warts, with an odds ratio of 3.65.
Introduction
Human papillomavirus (HPV) is a large and diverse group of viruses which include more than 100 HPV genotypes. Extensive sequence comparisons with the L1 gene sequence of HPV genotypes led to the classification "genus." most of the invasive cervical cancer, cervical intraepithelial neoplasia, and other anogenital cancers, including anal cancer and penile cancers. 2 They were further classified into high-risk, lowrisk, and probable high-risk categories according to their presence in cervical carcinoma. 3, 4 Although anogenital HPV infection has been studied extensively in women, data on male infection is relatively limited mainly because of the rarity of penile and anal carcinoma in men. However, studies of HPV in men are also important to understand the HPV disease burden in men and to prevent disease transmission between men and women.
Earlier studies of HPV infection in men usually rely on serological, clinical, or histological evaluation to establish a diagnosis of HPV infection, but polymerase chain reaction (PCR) has emerged as the most sensitive method for the detection of HPV. 5 Results from previous investigations have suggested that penile HPV in sexually active men is at least as prevalent as HPV in cervix among women. 6 However, HPV prevalence varies between countries both for men and women. 7 The purpose of our investigation was to assess the prevalence and genotype distribution of HPV in male patients in Taiwan.
Materials and methods
This is a retrospective study carried out in a tertiary referral center in northern Taiwan. One hundred consecutive male patients who came to our outpatient department for check of anogenital warts and were positive for HPV with PCR testing since May 1, 2003 were included. Patients who had been tested more than once were counted only once. The target lesions over the anal/perianal areas and coronal sulcus were collected by a moist cotton swab. Specimens on other drier areas were collected with the use of a nail file and Dacron swab as previously described in a HPV vaccine trial for males. 8 After centrifugation with 1500 rpm at 20 C for 5 minutes, the HPV DNA from each specimen was extracted with QIAamp 96 DNA blood kit (Qiagen, Venlo, The Netherlands). The extracted HPV DNA was amplified with a MY11/GP6 t consensus primer, and PCR was performed. Next, the genotyping of PCR products was carried out by using HPV genechip (EasyChip Ò HPV blot kit, King Car, Taipei, Taiwan) according to the hybridization, wash, and colorimetric reaction protocol. 9 EasyChip Ò HPV blot kit detected 39 genotypes of HPV DNA in a single reaction using nested multiplex PCR of L1 region of HPV (Table 2) . 10 The genechip can detect multiple infections at one time. 11 DNA sequencing analysis was also performed for the DNA product not hybridized in the genechip to detect the presence of other HPV genotypes.
Results
One hundred patients with 41 anal lesions (39.4%), three groin lesions (2.9%), and 60 penile lesions (57.7%) were studied. The mean age was 35.8 years (range 18e82). Most patients (88%) were between 18 and 49 years ( Table 3 ). The mean number of genotypes in the lesions of anus, penis, and groins were 1.41, 1.38, and 1.60, respectively. A total of 29 genotypes were detected in this study, and 26 of them were hybridized by the genechip. The three genotypes confirmed by direct sequencing were HPV 91, 144(FA83), and FA140. The most common HPV genotype in our patients was HPV 6 (46/100, 46%) followed by HPV 11 (28/100, 28%), HPV 16 (6/100, 6%), HPV 33 (5/100, 5%), HPV 66 (5/100, 5%), HPV 18 (4/100, 4%), HPV 53 (4/100, 4%), HPV 72 (4/100, 4%) ( Figure 1 ). Most patients (76%) were infected by one genotype, and coinfections with two, three, and four genotypes of HPV were present in 16%, 7%, and 1% of the patients, respectively (Table 4) . Five patients older than 60 years were infected by only one genotype, and 40% (2/5), 40% (2/5), and 20% (1/5) of these patients were infected by HPV 6, HPV 11, and HPV 16, respectively. Four patients with lesions on more than one site and three out of them (75%) had the same genotype of HPV on both sites.
The percentage of patients infected by HPV 6/11, HPV 16/18, and HPV 6/11/16/18 was 73%, 10%, and 77%, respectively. The relationship of the patients infected by HPV 6/11, non-HPV 6/11, HPV 6/11/ 16/18, and non-HPV 6/11/16/18 is demonstrated in Table 5 . Among the 10 patients infected by HPV 16/18, 60% (6/10) of the patients were coinfected by HPV 6/11 and 40% (4/10) were coinfected by HPV 42 (low risk), 45 (high risk), 69 (high risk), 72 (low risk). Sixtysix percent of the patients were infected by low-risk HPV, 12% by high-risk HPV, and 18% by both low-and high-risk HPV. The percentage of HPV 16 infection in penis was much higher than that in the anus, and the odds ratio was 3.65, whereas the percentage of HPV 18 infection in penile and anal specimen was similar (4.9% vs. 3.5%; odds ratio ¼ 0.71).
Twenty-four patients underwent skin biopsy of the lesions. Twenty lesions showed condylomata acuminata or squamous papilloma, of which 14 were infected by low-risk HPV genotypes alone. Five of these lesions were both infected by low-risk and highrisk types. Only one lesion of condylomata acuminata was singly infected by HPV 69, a high-risk type. Two lesions were diagnosed as verruca vulgaris, one of which was infected by HPV 11 (low risk) and the other by HPV 58 (high risk). Two patients with malignant lesions proved by skin biopsy harbored HPV 16 and HPV 33. One lesion of anal intraepithelial neoplasia revealed concurrent HPV 33 (high risk) and 72 (low risk) infections. Another lesion of erythroplasia of Queyrat manifested concurrent HPV 16 infection (high risk). Most of the benign lesions (20/22) showed low-risk HPV types, and both of the malignant lesions were infected by high-risk HPV genotypes. The pathological results correlated well with the HPV genotypes (Table 6) . Table 1 The relationships between genus, regional predilection, clinical lesions, and HPV genotypes. Genotypes in bold represent the HPV genotypes detected by the genechip or DNA sequencing analysis in this study. Three of our patients had HIV infections. One of them was infected by HPV 6, one was infected by HPV 72/33, and the other by HPV 6/66.
Discussion
HPVs are small, double-stranded DNA viruses of the Papovaviridae family. They are well known as an etiologic agent for benign warts of the skin and cervical carcinoma. Over 100 different genotypes of HPV have been identified according to the sequence of the L1 gene. According to the regional predilection, histopathology, and biology, the HPVs of a genus were categorized as cutaneous (nongenital) genotypes and genitalemucosal genotypes ( Table 1 ). The HPVs are further classified into high-risk, low-risk, and probable high-risk categories according to their malignant potential (Table 2) .
3,4 HPV 6 and 11 are the main mucosal genotypes of HPV causing anogenital warts in different studies, but may also affect nongenital skin.
12
HPV 16 and 18 are the two main mucosal genotypes of HPV causing cervical carcinoma worldwide, 13 whereas geographical variations exist in other cancer-causing genotypes. 14 In previous studies, HPV 52 and HPV 58 were found to be especially prevalent in Asia. 9 In several reports from Taiwan, HPV52 was the leading HPV detected in cervical specimen. 15, 16 In our study, the predominant HPV genotypes were HPV 6 (46/ 100, 46%) and HPV 11 (28/100, 28%) in all anogenital lesions in men. These results corresponded well to other studies in the USA, Hong Kong, and Italy. 17e19 In mainland China, the predominant HPV genotypes of male condylomata accuminata were HPV 6 (55.8%), HPV 11 (48.8%), HPV 18 (13.9%), and HPV 16/53/CP8304 (7%). 20 This result was also similar to our study, despite the high percentage of CP8304, which only contributed 1% (1/100) in our study. The resemblance might be explained by the frequent travel activities between these two countries. In Taiwanese females, 80% of condyloma contained HPV 6 or 11 sequences, and the predominant HPV genotypes in genital condyloma is HPV 11. 21 The presence of either HPV 6 or HPV 11 in our study was 73% (73/100), which was closely similar to the female data in Taiwan and China. 22 In our study group, we did not find a high prevalence of HPV 52 or HPV 58 reported in anogenital squamous cell neoplasia in Hong Kong, 23 mainland China, 22 and Taiwan 24 because most of the lesions in our study are benign entities; thus, the percentage of high risk genotypes infection was obviously lower. Thirty percent of the patients in this study were infected by high-risk genotypes of HPV, of which HPV 16 and 18 were responsible for one-third of the infection. HPV 16 was more common and had a higher association with penile warts than HPV 18 in our study, corresponding to the distribution in another study. 17 This result is due to the longer infection durations of HPV 16 compared to other genotypes. 25 Conventional treatments for anogenital HPV infection included podofilox solution or gel, imiquimod cream, cryotherapy, podophyllin resin, trichloroacetic acid, bichloroacetic acid, intralesional interferon, excision, curettage, electrosurgery, and laser surgery. 26 However, most of these methods destroy only the visible lesions. Latent HPV infection may persist and serve as a source of recurrence and transmission. 27, 28 Newer therapies, such as photodynamic therapy 28 and green tea catechins, 29 were reported to be effective, but the clearance rate was still not promising. Currently, there is no definitive treatment for anogenital HPV infection. Since HPV infection is subsequently cleared in more than two-thirds of the patients by the host immune response, 30 a wait-and-see policy is an option for less obvious clinical HPV lesions, especially for warts in the vaginal and anal canal. 31 Recently, a quadrivalent HPV vaccine (GardasilÔ) has become available for the prevention of HPV 6/11/16/18 for both females and males. The present study showed that 77% of male patients with anogenital warts were infected by one of HPV 6/11/16/18, and these patients might benefit from this quadrivalent HPV vaccine. However, we also found that 38% of male patients with anogenital warts were infected by other non-HPV 6/ 11/16/18. Therefore, the anticipated protective rate of the quadrivalent HPV vaccine would be only 62% for all HPV genotypes and was much lower than the proposed value (Table 5) . A similar result was observed in a study of the Australian HPV vaccine program, in which the quadrivalent HPV vaccine just produced a modest decline in heterosexual men (5.0%), and not in homosexual men. 32 The actual protective rate increased mildly in the new nine-valent (HPV 6/11/16/18/31/33/45/52/58) recombinant HPV L1 VLP vaccine, which will cover 66% of anogenital warts in men according to our study. However, even if the coverage rate was increased to 70%, the potential incremental gains of vaccinating males are limited according to the result of an individual-based HPV transmissiondynamic model. 33 Although general vaccination in males is not as cost-effective compared to that in females, it can still be considered as an option for males because of the high percentage of HPV6/11 and the possibility of HPV16/18 coinfection. The risk of HPV infection reduces with increasing age in women, 6, 34 but the incidence of HPV infection was constant over the age range 18e44 years in a previous study of men in the USA, 18 although the reason for the lack of age association with HPV incidence in men is not known. 35, 36 As expected, 88% of the patients in this study are in the age range 18e49 years ( Table 3 ). The reason for the younger age distribution may stem from the difference in sexual activity, for concern of transmission, or simply reflects the trend for spontaneous remission of HPV infection. This study has several noteworthy limitations, such as its crosssectional nature, lack of representation of the general population due to referral bias, and the need to self-pay for HPV typing tests. Moreover, an unreliable history of sexual activity and homosexual behavior also restricts in-depth discussion in this study.
In summary, to the best of our knowledge, this is the largest study of HPV genotypes of anogenital warts in Taiwanese males, and the result serves as a reference for male individuals who might consider taking HPV vaccination. Our study confirmed the role of HPV 6 and 11 as the major causes of anogenital warts in Taiwanese males. Coinfection of high-and low-risk HPV is common and has an important implication in terms of disease prevention and treatment for both males and females. Although HPV vaccination for the prevention of HPV infection in men might be less cost-effective than that in females, it can be still recommended because of the high percentage of HPV 6/11 and the possibility of HPV 16/18 coinfection in clinically apparent anogenital warts in men.
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The relationship between the patients infected by HPV 6/11, the patients infected "only" by HPV 6/11, and the patients infected by both HPV 6/11 and non-HPV 6/11 HPV 6/11 (Only HPV 6/11 þ HPV 6/11 and non-HPV 6/11) 73% Only HPV 6/11 57% HPV 6/11 and non-HPV 6/11 16% Non-HPV 6/11 27%
The relationship between the patients infected by HPV 6/11/16/18, the patients infected "only" by HPV 6/11/16/18, and the patients infected by both HPV a These genotypes are found in more than 20% of the lesions.
